Review



ro25 6981 ro  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Tocris ro25 6981 ro
    Ro25 6981 Ro, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ro25 6981 ro/product/Tocris
    Average 93 stars, based on 17 article reviews
    ro25 6981 ro - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    ro25 6981 maleate  (Alomone Labs)
    94
    Alomone Labs ro25 6981 maleate
    Ro25 6981 Maleate, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ro25 6981 maleate/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    ro25 6981 maleate - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    r-180  (alomone labs)
    94
    alomone labs r-180
    R 180, supplied by alomone labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r-180/product/alomone labs
    Average 94 stars, based on 1 article reviews
    r-180 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    ro25 6981 ro  (Tocris)
    93
    Tocris ro25 6981 ro
    Ro25 6981 Ro, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ro25 6981 ro/product/Tocris
    Average 93 stars, based on 1 article reviews
    ro25 6981 ro - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    ro25 6981 maleate  (Tocris)
    93
    Tocris ro25 6981 maleate
    Ro25 6981 Maleate, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ro25 6981 maleate/product/Tocris
    Average 93 stars, based on 1 article reviews
    ro25 6981 maleate - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    αr,βs)-α-(4-hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (ro25-6981  (Tocris)
    90
    Tocris αr,βs)-α-(4-hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (ro25-6981
    A ) Diagram of pharmacological treatment timeline (below) and associated periods of mEPSC analysis (top). After establishing whole-cell voltage-clamp recording of an individual lamina I neuron, a control <t>aCSF</t> period was recorded, followed by subsequently adding 1 <t>µM</t> <t>Ro25-6981,</t> then 10 µM DQP-1105, and finally 10 µM TCN-201. B) Histograms of the proportion of mEPSCs in each decay constant bin during administration of control aCSF (left), 1 µM Ro25-6981 to block GluN2B NMDARs (middle left), 1 µM Ro25-6981 + 10 µM DQP-1105 to block GluN2B and GluN2D NMDARs (middle right), and 1 µM Ro25-6981 + 10 µM DQP-1105 + 10 µM TCN-201 to block GluN2B, GluN2D, and GluN2A NMDARs.
    αr,βs) α (4 Hydroxyphenyl) β Methyl 4 (Phenylmethyl) 1 Piperidinepropanol Maleate (Ro25 6981, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/αr,βs)-α-(4-hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (ro25-6981/product/Tocris
    Average 90 stars, based on 1 article reviews
    αr,βs)-α-(4-hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (ro25-6981 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    nmda receptors antagonist ro25 6981 maleate  (Tocris)
    96
    Tocris nmda receptors antagonist ro25 6981 maleate
    A ) Diagram of pharmacological treatment timeline (below) and associated periods of mEPSC analysis (top). After establishing whole-cell voltage-clamp recording of an individual lamina I neuron, a control <t>aCSF</t> period was recorded, followed by subsequently adding 1 <t>µM</t> <t>Ro25-6981,</t> then 10 µM DQP-1105, and finally 10 µM TCN-201. B) Histograms of the proportion of mEPSCs in each decay constant bin during administration of control aCSF (left), 1 µM Ro25-6981 to block GluN2B NMDARs (middle left), 1 µM Ro25-6981 + 10 µM DQP-1105 to block GluN2B and GluN2D NMDARs (middle right), and 1 µM Ro25-6981 + 10 µM DQP-1105 + 10 µM TCN-201 to block GluN2B, GluN2D, and GluN2A NMDARs.
    Nmda Receptors Antagonist Ro25 6981 Maleate, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nmda receptors antagonist ro25 6981 maleate/product/Tocris
    Average 96 stars, based on 1 article reviews
    nmda receptors antagonist ro25 6981 maleate - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    A ) Diagram of pharmacological treatment timeline (below) and associated periods of mEPSC analysis (top). After establishing whole-cell voltage-clamp recording of an individual lamina I neuron, a control aCSF period was recorded, followed by subsequently adding 1 µM Ro25-6981, then 10 µM DQP-1105, and finally 10 µM TCN-201. B) Histograms of the proportion of mEPSCs in each decay constant bin during administration of control aCSF (left), 1 µM Ro25-6981 to block GluN2B NMDARs (middle left), 1 µM Ro25-6981 + 10 µM DQP-1105 to block GluN2B and GluN2D NMDARs (middle right), and 1 µM Ro25-6981 + 10 µM DQP-1105 + 10 µM TCN-201 to block GluN2B, GluN2D, and GluN2A NMDARs.

    Journal: bioRxiv

    Article Title: Heterogeneity of synaptic NMDA receptor responses within individual lamina I pain processing neurons across sex in rats and humans

    doi: 10.1101/2023.08.09.550677

    Figure Lengend Snippet: A ) Diagram of pharmacological treatment timeline (below) and associated periods of mEPSC analysis (top). After establishing whole-cell voltage-clamp recording of an individual lamina I neuron, a control aCSF period was recorded, followed by subsequently adding 1 µM Ro25-6981, then 10 µM DQP-1105, and finally 10 µM TCN-201. B) Histograms of the proportion of mEPSCs in each decay constant bin during administration of control aCSF (left), 1 µM Ro25-6981 to block GluN2B NMDARs (middle left), 1 µM Ro25-6981 + 10 µM DQP-1105 to block GluN2B and GluN2D NMDARs (middle right), and 1 µM Ro25-6981 + 10 µM DQP-1105 + 10 µM TCN-201 to block GluN2B, GluN2D, and GluN2A NMDARs.

    Article Snippet: Pharmacology experiments were performed by acutely perfusing selective NMDAR antagonists onto a slice, following the control ACSF period. (αR,βS)-α-(4-Hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (Ro25-6981) , 4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic acid (DQP-1105) , and (3-chloro-4-fluoro-N-[(4-([2-(phenylcarbonyl)hydrazino]carbonyl) phenyl)methyl]benzene-sulfonamide) (TCN-201) ( )were obtained from Tocris Bioscience.

    Techniques: Control, Blocking Assay